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The growing need for drug-delivery systems that release
their contents in a desired fashion has intensified research
for “smart carriers” with intelligent properties.[1–3] Com-
pared to more established delivery vehicles, such as poly-
meric micelles,[4] liposomes, and small colloidal particles,[5]
polymeric polyelectrolyte multilayered[6] capsules[7, 8] are
emerging materials with high potential as macromolecular
drug-delivery systems.[9–12] The major advantages of these
microcapsules are their loading capacity and the possibility
to precisely tailor their properties by choosing the compo-
nents of the capsules. Considerable amounts of macromolec-
ular therapeutics can be encapsulated inside these capsu-
les[13] and, depending on the choice of coating material (i.e.,
synthetic or biological), one can render capsules nondegrad-
able or degradable.[11] Also, their mechanical strength can
be tailored by varying the number of coating layers,[14] inclu-
sion of nanoparticles,[15] or by thermal treatment.[16, 17] Once
their target site is reached, it is of utmost importance to
have a mechanism that causes release of encapsulated spe-
cies from these capsules. Externally triggered release has re-
cently been shown to be possible by laser-light illumina-
tion.[18–20] The principle of this system is based on heating of
metal nanoparticles, which causes changes in permeability
of the outer shell and even total disruption of the shell, fi-
nally resulting in the release of the encapsulated material.[20]
These laser-light-sensitive capsules could, for example, be
activated after cellular uptake[21] or be used for transdermal
activated-drug release.
Herein, we report the use of ultrasound to trigger re-
lease from multilayered capsules. Ultrasound has been used
widely in biomedical applications[22] for improving drug
uptake, anti-inflammatory treatment, or imaging. Upon
propagation, an ultrasound wave undergoes both viscous
and thermal absorption as well as scattering.[23,24] At low fre-
quency the temperature difference between the particle and
the medium will be in equilibrium, whereas at high frequen-
cy only a small portion of the surface will be affected by
thermal waves. Similar frequency dependence is applicable
to viscous losses, wherein extensive particle motion occurs
at low frequency while little movement takes place at high
frequencies. Figure 1 shows schematically the fabrication of
the capsules and the effect of ultrasound on their integrity.
When the capsules are subjected to ultrasound, a morpho-
logical change of the capsule wall occurs due to the creation
of shear forces between the successive fluid layers, which re-
sults in the disruption of the capsule membrane and release
of encapsulated species.
Multilayered capsules were fabricated using the LbL
technique by successive coating of CaCO3 microparticles
with different layers of polyelectrolytes and gold nanoparti-
cles. This process is shown schematically in Figure 1. During
fabrication, the CaCO3 microparticles were filled with
2000-kDa fluorescein isothiocyanate (FITC)-labeled dextran
by co-precipitation. This is an elegant method, which allows
a high degree of loading and avoids a post-filling step of the
capsules. Co-encapsulation in CaCO3 microparticles is typi-
cally performed in the case of macromolecules, and leads to
a large quantity of encapsulated macromolecules without
loss of biological activity.[13] This approach is less suited to
the encapsulation of low-molecular-weight drugs, as such
molecules would tend to diffuse outwards during LbL coat-
ing of the CaCO3 microparticles, or they would diffuse out-
wards through the LbL membrane upon dissolution of the
CaCO3.
Two different types of capsules were fabricated: Type 1
consisted solely of polyelectrolytes, while type 2 were hybrid
capsules consisting of polyelectrolytes and gold nanoparti-
cles (AuNPs). Sodium poly(styrene sulfonate) (PSS) was
used as polyanion while poly(allylamine hydrochloride)
(PAH) was used as polycation. AuNPs were fabricated ac-
cording to the method reported by Kimura et al. ,[25] which
resulted in AuNPs with a diameter ranging from 1 to 5 nm
(as verified by transmission electron microscopy; data not
shown) and a negative surface charge (as verified by meas-
uring the electrophoretic mobility) due to the presence of
carboxyl groups on the surface of the AuNPs. Multilayer
buildup between the PSS/PAH (in the case of type 1 cap-
ACHTUNGTRENNUNGsules) and AuNP/PAH (in the case of type 2 capsules) was
driven by the electrostatic interactions between the cationic
amino groups of the PAH and the anionic sulfonate of the
PSS and carboxyl groups, respectively. For each type of cap-
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sule a total of four bilayers was deposited on the surface of
the CaCO3 microparticles, followed by dissolution of the
CaCO3 by treatment with ethylenediaminetetraacetic acid
(EDTA). EDTA forms complexes with the calcium and per-
meates easily through the multilayer membrane, which re-
sults in hollow capsules with an average diameter of 4 mm.
The FITC-dextrans initially entrapped inside the pores of
the CaCO3 microparticles are too large to permeate through
the multilayered membrane and stay encapsulated inside
the hollow capsules.
Figure 2 shows optical transmission, confocal, and scan-
ning electron microscopy (SEM) images of the obtained
capsules. In the optical transmission images both types of
capsule appear transparent. However, the (PSS/PAH)4 cap-
sules are barely visible, whereas the (AuNP/PAH)4 capsules
appear significantly darker. These observations are consis-
tent with the appearance of the capsules in suspension,
which is a slightly turbid but clear suspension in the case of
(PSS/PAH)4 capsules and a dark-brown suspension for
(AuNP/PAH)4 capsules. The dark appearance of the (AuNP/
PAH)4 capsules is due to the absorption of light by the
AuNPs. In the confocal images in Figure 2B and F, a homo-
geneous filling of the capsules with green fluorescence is ob-
served, which indicates no preferential accumulation of fluo-
rescence in particular parts of the capsules. The SEM
images in Figure 2C, D, G and H show in detail the mor-
phology of the capsules. Apparently, the (PSS/PAH)4 cap-
ACHTUNGTRENNUNGsules have a much smoother morphology compared to the
(AuNP/PAH)4 capsules. This is most likely due to the pres-
ence of the AuNPs within the multilayer membrane, which
offer a more rigid structure that appears rather rough upon
drying.
Figure 1. Schematic representation of the encapsulation and release of species in/from polyelectrolyte capsules. Calcium carbonate microparti-
cles with macromolecules in their pores are coated with polyelectrolytes (light gray lines) and nanoparticles (black dots) using the layer-by-
layer (LbL) technique (step A). After dissolution of the calcium carbonate, hollow capsules are obtained (step B). Before ultrasound irradiation,
the capsules, which consist of polyelectrolytes and nanoparticles, form a closed structure that keeps high-molecular-weight species encapsu-
lated. After ultrasound irradiation (step C) the membrane should rupture, thus leading to the release of encapsulated species.
Figure 2. A,E) Optical transmission and B,F) confocal microscopy images of (PSS/PAH)4 (A and B) and (AuNP/PAH)4 (E and F) capsules. The
contrast is due to the FITC-dextrans encapsulated in the capsules. SEM images of C,D) (PSS/PAH)4 capsules and G,H) (AuNP/PAH)4 capsules.
Note that these images were recorded before ultrasonic treatment.
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To evaluate the effect of ultrasound on the integrity of
the wall of the capsules, suspensions of capsules were sub-
jected to treatment with an ultrasonic probe operating at a
frequency of 20 kHz and a power output of 20, 40, and
100 W for 1, 5, and 10 s, respectively. Initially, the capsules
are nearly monodisperse spherically shaped. However, after
sonication for 1 s at 20 W a large number of capsules are
broken and a lot of debris of broken capsules can be detect-
ed. When the capsules are subjected to ultrasound at an
output power of 100 W, almost no intact capsules are ob-
served and nothing is left but unidentifiable debris of
broken capsules. The ultrasonic shock waves originating
from the ultrasound probe propagate through the liquid and
cause high shear forces between the successive liquid layers.
When such shear forces cleave through the membrane of
the capsules, the membrane is torn apart and the capsules
are destroyed. Figure 3 shows optical transmission, confocal,
and SEM images of the capsules after ultrasonic treatment.
The capsules are clearly destroyed and empty, the only fluo-
rescence detected being on the walls of broken capsules due
to electrostatic or hydrophobic interactions between the
florescent dye and the remaining polyelectrolytes. Whereas
before ultrasonic treatment the capsules had a round shape
in the electron microscopy images, they are extremely de-
formed after ultrasonic treatment and individual capsules
can hardly be detected. Figure 3D and H shows SEM
images at higher magnification of, most likely, a destroyed
capsule. From the irregularities of the surface one can clear-
ly see the impact of the ultrasound on the integrity of the
capsule wall, as large holes and cracks are present.
To quantify the effect of ultrasonic treatment on the in-
tegrity of the capsules, the numbers of intact and destroyed
capsules after ultrasonic treatment were determined for the
different parameters of treatment time and power output.
Logically, before ultrasonic treatment, no broken capsules
are observed. After ultrasonic treatment for 1 s a consider-
ACHTUNGTRENNUNGable number of capsules are already broken, and increasing
the treatment time results in an increasing quantity of
broken capsules. Also, an increase in power input results in
an increase in the number of broken capsules. These trends
are presented graphically in Figure 4. Remarkably, an influ-
ence of the presence of AuNPs can also be observed. In the
case when ultrasonic treatment is performed for 10 s, virtu-
ally all capsules are destroyed, irrespective of the presence
of nanoparticles in the capsulesF shell. However, for shorter
treatment times, the capsules appear mechanically more
stable when nanoparticles are included in the shell. On com-
paring Figure 4A and B, one observes that after 1 and 5 s of
ultrasonic treatment almost double the quantity of (PSS/
PAH)4 capsules are broken compared to the number of
broken (AuNP/PAH)4 capsules. The high density of carboxyl
groups on the surface of the AuNPs[25] offers good binding
sites with the PAH, which makes the multilayer structure
more rigid than in the case of PSS/PAH multilayers. There-
fore, such hybrid multilayers that consist of nanoparticles
and polyelectrolytes are most likely more stable toward ul-
trasound than multilayers consisting solely of polyelectro-
lytes.
In conclusion, remote release of encapsulated species
from multilayered capsules has been induced by ultrasound
irradiation. It was shown that such irradiation has a dramat-
ic effect on the integrity of multilayered capsules, and leads
to their destruction and the release of the encapsulated spe-
cies. Ultrasound offers an easy and fast way of inducing re-
lease from multilayered capsules and may be of interest to
the biomedical field, for example, in topical application of
ultrasound after subcutaneous injection of capsules. The
capsules presented here consisted of synthetic building
Figure 3. A,E) Optical transmission and B,F) confocal microscopy images of (AuNP/PAH)4 (A and B) and (PSS/PAH)4 (E and F) capsules after
ultrasonic treatment. SEM images of C,D) (PSS/PAH)4 capsules and G,H) (AuNP/PAH)4 capsules after ultrasonic treatment.
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blocks and therefore cannot be directly translated to clinical
reality, nor can the high ultrasound power that was used for
the destruction of the capsules. Therefore, in our present re-
search we are focusing on the use of biocompatible building
blocks and the incorporation of ultrasound contrast agents,
which could lower the required power for the breakup of
capsules.
Experimental Section
Materials: PAH (weight-average molecular weight Mw
70 kDa), PSS (Mw70 kDa), and FITC-dextran (Mw2000 kDa)
were purchased from Sigma–Aldrich-Fluka. NaCl, EDTA, CaCl2,
and Na2CO3 were purchased from Merck. AuNPs were synthe-
sized according to Kimura et al.[25] All water used in the experi-
ments was of Milli-Q grade.
Fabrication of calcium carbonate microparticles: CaCO3 mi-
croparticles were fabricated according to Volodkin et al.[26,27]
Briefly, CaCl2 and Na2CO3 solutions (0.33m) were mixed under
vigorous stirring for 30 s, which led to the precipitation of CaCO3
microparticles. Subsequently, four centrifugation and washing
steps with pure water were performed to remove the unreacted
species. In a last step, the particles were washed with acetone
and subsequently air-dried. FITC-dextran was incorporated in the
CaCO3 microparticles by co-precipitation.
[13] Thus, FITC-dextran
(5 mg) was dissolved in the CaCl2 solution (3.5 mL) before
mixing with the Na2CO3 solution.
Fabrication of multilayered capsules: Capsules were fabricat-
ed in a two-step procedure. In the first step, the CaCO3 micropar-
ticles were coated using the LbL technique. FITC-dextran (20 mg)
containing CaCO3 microparticles was dispersed in a solution of
NaCl (0.5m) containing PSS (2 mgmL1) or AuNPs (1 mgmL1).
The dispersion was continuously shaken for 10 min. The excess
PSS or AuNPs were removed by two centrifugation/washing
steps with deionized water. Thereafter, NaCl solution (0.5m,
1 mL) containing PAH (2 mgmL1) was added and the dispersion
was continuously shaken for 10 min, followed again by two cen-
trifugation/washing steps. This procedure was repeated four
times until four bilayers were deposited on the surface of the
CaCO3 microparticles. In a second step, the CaCO3 core was re-
moved by complexation with EDTA. Thus, the coated CaCO3 mi-
croparticles were shaken for 30 min with EDTA solution (0.2m,
1 mL, pH 5) followed by centrifugation and redispersion in fresh
EDTA solution (1 mL). This procedure was repeated four times to
ensure complete removal of the CaCO3 core, as previously report-
ed by Volodkin et al.[26] Finally, the thus obtained hollow micro-
capsules filled with FITC-dextran were washed four times with
water.
Ultrasonic treatment: Ultrasound irradiation was performed
with a Branson Sonifier 250 equipped with a titanium microtip
and operated at a constant-output frequency of 20 kHz. The mi-
crotip was positioned in a suspension of capsules (250 mL) in a
500-mL Eppendorf microtube. Subsequently, ultrasound irradia-
tion was applied at different output powers for different times.
Confocal microscopy: Confocal microscopy and transmission
light microscopy images were recorded with a Biorad MRC 1024
confocal system. An inverted microscope (Eclipse TE300D,
Nikon) equipped with a 60A water-immersion objective lens was
used.
SEM: A drop of capsule suspension was deposited onto a
silicon wafer and dried under a nitrogen stream, followed by
sputtering with gold. SEM images were recorded with an FEI
Quanta 200 FEG scanning electron microscope operated at an
acceleration voltage of 5 kV.
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Figure 4. Percentage of broken A) (PSS/PAH)4 and B) (AuNP/PAH)4
capsules after ultrasound irradiation as function of irradiation time
and output power. For each value 50 capsules were counted.
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